Assignee
FUNDACION PARA LA INVESTIG MEDICA APLICADA
ES·7 granted patents·11 pending applications·4 citations·filing 2015–2023
Top patents by PatentIndex Score
18 records- 0179US11147887B2Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson diseaseFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2015·Granted Oct 19, 2021·4 cites·21 claims
- 0266US2026026479A1Genetically engineered mice models for multiple myelomaFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2023·Application pending·0 cites
- 0357US2026007697A1New chimeric antigen receptor (car) cells and medical uses thereofFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2023·Application pending·0 cites
- 0456US11560407B2FOXP3-binding peptides and uses thereofFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2020·Granted Jan 24, 2023·0 cites·10 claims
- 0556US2025186623A1Expression system for the treatment of cancerFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2023·Application pending·0 cites
- 0656US2025188143A1Combined gene and radio therapy for the treatment of cancerFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2023·Application pending·0 cites
- 0755US2022008559A1Nucleic acid constructs and gene therapy vectors for use in the treatment of wilson diseaseFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2021·Application pending·0 cites
- 0852US10654896B2FoxP3-binding peptides and uses thereofFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2017·Granted May 19, 2020·0 cites·18 claims
- 0950US2023277687A1Viral particles for use in treating tauopathies such as alzheimer's diseases by gene therapyFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2021·Application pending·0 cites
- 1045US2023265456A1Gene therapy vector expressing cyp27a1 for the treatment of cerebrotendinous xanthomatosisFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2021·Application pending·0 cites
- 1145US2020087666A1Compounds targeting long non coding rna for the treatment of cancerFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2018·Application pending·0 cites
- 1240US11390854B2Human porphobilinogen deaminase derived proteins and polynucleotides and uses thereofFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2017·Granted Jul 19, 2022·0 cites·31 claims
- 1340US11118238B2Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson's disease and other conditionsFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2015·Granted Sep 14, 2021·0 cites·24 claims
- 1437US2022233722A1cPLA2e INDUCING AGENTS AND USES THEREOFFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2020·Application pending·0 cites
- 1525US10407423B2Compounds as inhibitors of DNA methyltransferasesFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2016·Granted Sep 10, 2019·0 cites·18 claims
- 1624US2019127354A12,4,6,7-tetrasubstituted quinoline compounds as inhibitors of dna methyltransferasesFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2016·Application pending·0 cites
- 1724US2020025765A1In vitro method for the diagnosis of lung cancerFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2018·Application pending·0 cites
- 1822US9969744B2Compounds for use in cognition improvementFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2015·Granted May 15, 2018·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when FUNDACION PARA LA INVESTIG MEDICA APLICADA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →